vcfirmsdirectory.com

Venture capital · Growth stage · Est. 2005

BioStar Capital

BioStar Capital is a US venture capital firm that invests in transformative medical technologies, combining clinicians, healthcare executives and finance professionals in its team and evaluation process.

Charlevoix · Rocky RiverRegistered · Charlevoix
New investments · 12 months
Fund vehiclesPublic
10
10 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: biostarcapital.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round BioStar Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is BioStar Capital right for your round?

Is BioStar Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
10
10 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

BIOSTAR VENTURES V, L.P.US private fund · Active · United States · $106.7M gross assets · filed 31 Mar 2026
BIOSTAR VENTURES III-XF, LPUS private fund · Active · United States · $35M gross assets · filed 31 Mar 2026
BIOSTAR FUND V MMI SPV I, LLCUS private fund · Active · United States · $29.2M gross assets · filed 31 Mar 2026
BIOSTAR VENTURES III, LPUS private fund · Active · United States · $18.2M gross assets · filed 31 Mar 2026
BIOSTAR VENTURES V-A, L.P.US private fund · Active · United States · $16.8M gross assets · filed 31 Mar 2026
BIOSTAR V AVS GR SPV II, LLCUS private fund · Active · United States · $10M gross assets · filed 31 Mar 2026
BIOSTAR V AVS GR SPV, LLCUS private fund · Active · United States · $9.7M gross assets · filed 31 Mar 2026
BIOSTAR VENTURES II, LPUS private fund · Active · United States · $604.3K gross assets · filed 31 Mar 2026
BIOSTAR VENTURES II-A, LPUS private fund · Active · United States · $118.8K gross assets · filed 31 Mar 2026
BIOSTAR VENTURES III-XF ASI SPV LLCUS private fund · Active · United States · $39.8K gross assets · filed 31 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds BioStar Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, BioStar Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

Amplitude Vascular Systems (AVS)

Portfolio and exits

Every company BioStar Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where BioStar Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet BioStar Capital

Events where BioStar Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet BioStar Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

8 Oct 2026New deal
31 Mar 2026Fund filingForm ADV filed by BIOSTAR CAPITAL: 10 private funds, $226.3M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

BioStar Capital is based in Charlevoix, United States. It also has an office in Rocky River.

In 2005.

10 fund vehicles are on public registers (SEC adviser filings), including BIOSTAR VENTURES V, L.P., BIOSTAR VENTURES III-XF, LP and BIOSTAR FUND V MMI SPV I, LLC.

Stages: Late stage. Sectors: Medtech, Robotics. From the firm’s own website.

Backs medical technology innovation addressing unmet patient needs, with emphasis on cardiovascular and orthopedics. Proprietary deal flow from healthcare networks is vetted by physician Medical Venture Partners, and the team then helps portfolio companies reach clinical and commercial goals and exit. From the firm’s own website.

BioStar Capital lists 1 portfolio company on its website: Amplitude Vascular Systems (AVS).

Know before BioStar Capital’s next round is announced.

PRO tracks BioStar Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

BioStar CapitalGet BioStar Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.